Twist Bioscience Corporation
TWST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $2 | $2 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 3.1% | 3.5% | 4.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 51.3% | 53.4% | 49.6% | 48.3% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -21.1% | 27.5% | -35.1% | -28.3% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -27.4% | 21.2% | -42.4% | -35.6% |
| EPS Diluted | -0.45 | 0.33 | -0.66 | -0.53 |
| % Growth | -236.4% | 150% | -24.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |